YD Bio Ltd (YDES) income statement
YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 5/30
$4.85+0.12 (+2.54%)
Close on Nov 18, 2026Market cap $343.33MP/E –Yield –
YD Bio Ltd income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 28.1%
- Operating margin
- -883.3%
- Net margin
- -1392.6%
- Return on equity, FY2025
- -445.1%
Financial strength
- Current ratio
- 5.23
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 249.0%
Valuation
- P/E ratio
- –
- Price to sales
- 575.26
- Price to book
- 76.74
- Dividend yield
- –
See a number that looks wrong?